| Product Code: ETC8977969 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Romania Patented Drugs Market Overview |
3.1 Romania Country Macro Economic Indicators |
3.2 Romania Patented Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Romania Patented Drugs Market - Industry Life Cycle |
3.4 Romania Patented Drugs Market - Porter's Five Forces |
3.5 Romania Patented Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.6 Romania Patented Drugs Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
3.7 Romania Patented Drugs Market Revenues & Volume Share, By Indication, 2021 & 2031F |
4 Romania Patented Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in Romania |
4.2.2 Growing healthcare expenditure in the country |
4.2.3 Government initiatives to promote research and development in the pharmaceutical sector |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for patented drugs |
4.3.2 Price controls and reimbursement policies impacting profit margins of pharmaceutical companies |
4.3.3 Competition from generic drug manufacturers affecting market share of patented drugs |
5 Romania Patented Drugs Market Trends |
6 Romania Patented Drugs Market, By Types |
6.1 Romania Patented Drugs Market, By Distribution Channel |
6.1.1 Overview and Analysis |
6.1.2 Romania Patented Drugs Market Revenues & Volume, By Distribution Channel, 2021- 2031F |
6.1.3 Romania Patented Drugs Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.1.4 Romania Patented Drugs Market Revenues & Volume, By Drug Store and Retail Pharmacies, 2021- 2031F |
6.1.5 Romania Patented Drugs Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.2 Romania Patented Drugs Market, By Dosage Form |
6.2.1 Overview and Analysis |
6.2.2 Romania Patented Drugs Market Revenues & Volume, By Solid Drug Product, 2021- 2031F |
6.2.3 Romania Patented Drugs Market Revenues & Volume, By Liquid Drug Product, 2021- 2031F |
6.2.4 Romania Patented Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Romania Patented Drugs Market, By Indication |
6.3.1 Overview and Analysis |
6.3.2 Romania Patented Drugs Market Revenues & Volume, By Cardiovascular Diseases, 2021- 2031F |
6.3.3 Romania Patented Drugs Market Revenues & Volume, By Cancer, 2021- 2031F |
6.3.4 Romania Patented Drugs Market Revenues & Volume, By Autoimmune Diseases, 2021- 2031F |
6.3.5 Romania Patented Drugs Market Revenues & Volume, By Others, 2021- 2031F |
7 Romania Patented Drugs Market Import-Export Trade Statistics |
7.1 Romania Patented Drugs Market Export to Major Countries |
7.2 Romania Patented Drugs Market Imports from Major Countries |
8 Romania Patented Drugs Market Key Performance Indicators |
8.1 Research and development investment in the pharmaceutical sector |
8.2 Number of new drug patents granted in Romania |
8.3 Adoption rate of innovative patented drugs in the market |
9 Romania Patented Drugs Market - Opportunity Assessment |
9.1 Romania Patented Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.2 Romania Patented Drugs Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
9.3 Romania Patented Drugs Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 Romania Patented Drugs Market - Competitive Landscape |
10.1 Romania Patented Drugs Market Revenue Share, By Companies, 2024 |
10.2 Romania Patented Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here